Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms
about
Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoproteinComparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines.A "prime-pull" vaccine strategy has a modest effect on local and systemic antibody responses to HIV gp140 in miceA Comparison of Red Fluorescent Proteins to Model DNA Vaccine Expression by Whole Animal In Vivo Imaging.Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses.Thymic stromal lymphopoietin (TSLP) acts as a potent mucosal adjuvant for HIV-1 gp140 vaccination in miceNew prospects for a preventive HIV-1 vaccine.Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection.Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations.Airway T cells protect against RSV infection in the absence of antibody.Mouse Models of Influenza Infection with Circulating Strains to Test Seasonal Vaccine Efficacy.
P2860
Q28730561-86B4F7B1-3263-4B44-AFE5-AD9DD1A7B6F5Q33847809-2058020B-79F4-4FA0-AF8D-3A82A46C5CCFQ35049110-09689DE1-12A1-4177-90EC-4FAF0BACD01EQ35668694-C2FC7A8A-057D-4DFA-91C8-EF463BFC0D01Q35913930-389F5B2A-2F4D-40B0-B57D-C7AEECEDB5A4Q36043882-85C6EEFE-7C92-4281-A52A-040EB45B5F94Q36223864-621D5FD5-FA2F-4058-8208-16DBEAB0AAE4Q36747814-3E9C5741-B003-40C8-9FED-88C436440690Q37187433-8F161675-83AB-4814-AAD9-73D93192AAE9Q40188450-E0E4B6F2-A3FD-4FF0-86FA-92717385A3F8Q49409333-4E364FB5-D855-4349-873E-E5C251542102
P2860
Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Intravaginal immunization usin ...... lyophilized solid dosage forms
@ast
Intravaginal immunization usin ...... lyophilized solid dosage forms
@en
type
label
Intravaginal immunization usin ...... lyophilized solid dosage forms
@ast
Intravaginal immunization usin ...... lyophilized solid dosage forms
@en
prefLabel
Intravaginal immunization usin ...... lyophilized solid dosage forms
@ast
Intravaginal immunization usin ...... lyophilized solid dosage forms
@en
P2093
P2860
P50
P1433
P1476
Intravaginal immunization usin ...... lyophilized solid dosage forms
@en
P2093
A David Woolfson
Gavin P Andrews
Louise Donnelly
Rhonda M Curran
Ryan J Morrow
P2860
P304
P356
10.1016/J.VACCINE.2011.04.023
P407
P577
2011-04-21T00:00:00Z